Aarkstore - Interleukin-2 (IL-2) Receptor Agonists -Pipeline Insights, 2014 - PowerPoint PPT Presentation

Loading...

PPT – Aarkstore - Interleukin-2 (IL-2) Receptor Agonists -Pipeline Insights, 2014 PowerPoint presentation | free to download - id: 6c0edc-ZjdkZ



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Aarkstore - Interleukin-2 (IL-2) Receptor Agonists -Pipeline Insights, 2014

Description:

DelveInsights,Interleukin-2 (IL-2) Receptor Agonists-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Interleukin-2 (IL-2) Receptor Agonists. – PowerPoint PPT presentation

Number of Views:6

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Interleukin-2 (IL-2) Receptor Agonists -Pipeline Insights, 2014


1
Interleukin-2 (IL-2) Receptor Agonists
-Pipeline Insights, 2014
Category Pharmaceuticals Healthcare
  • Browse Complete Report -
  • http//www.aarkstore.com/pharmaceuticals-healthcar
    e/75780/interleukin-2-il-2-receptor-agonists-pipel
    ine-insights-2014

2
Summary
  • DelveInsights,Interleukin-2 (IL-2) Receptor
    Agonists-Pipeline Insights, 2014, report provides
    comprehensive insights about pipeline drugs
    across this mechanism of action (MOA). A key
    objective of the report is to establish the
    understanding for all the pipeline drugs that
    fall under Interleukin-2 (IL-2) Receptor
    Agonists. This report provides information on the
    therapeutic development based on the
    Interleukin-2 (IL-2) Receptor Agonists dealing
    with mechanism of action, comparative analysis at
    various stages covering Filed, Phase III, Phase
    II, Phase I, IND filed, Preclinical, Discovery
    and unknown stages, therapeutics assessment by
    monotherapy and combination products and molecule
    type drug information. The report also covers the
    companies information involved in the therapeutic
    development of the products. It also has
    highlighted the discontinued and dormant
    products.

3
Summary
  • Data Sources
  • The report is built using data and information
    sourced from proprietary databases, primary and
    secondary research and in-house analysis by
    DelveInsight team of industry experts. Secondary
    sources information and data has been collected
    from various printable and non-printable sources
    like search engines, News websites, Government
    Websites, Trade Journals, White papers,
    Magazines, Trade associations, Books, Industry
    Portals, Industry Associations and access to
    available databases. Please note this report
    requires certain updates. We have all the
    information available but require 3 business days
    to complete the process and ensure it is as
    up-to-date as possible. Certain sections in the
    report may be removed or altered based on the
    availability and relevance of data for the
    indicated mechanism of action.  

4
Summary
  • Scope 
  • The report provides a snapshot of the global
    therapeutic landscape of Interleukin-2 (IL-2)
    Receptor Agonists The report provides pipeline
    products under drug profile section which
    includes product description, MOA, licensors
    collaborators, development partner and chemical
    information Coverage of the Interleukin-2 (IL-2)
    Receptor Agonists pipeline on the basis of
    target, MOA, route of administration, technology
    involved and molecule type The report reviews key
    players involved in the therapeutics development
    for Interleukin-2 (IL-2) Receptor Agonists and
    also provide company profiling The report also
    gives the information of dormant and discontinued
    pipeline projects  Pipeline products coverage
    based on various stages of development ranging
    from preregistration till discovery and
    undisclosed stages  Provides pipeline assessment
    by monotherapy and combination therapy products,
    stage of development and molecule type

5
Summary
  • Reasons to buy Complete MOA intelligence and
    complete understanding over therapeutics
    development for Interleukin-2 (IL-2) Receptor
    Agonists Identify the relationship between the
    drugs and use it for target finding, drug
    repurposing, and precision medicine. Devise
    corrective measures for pipeline projects by
    understanding Interleukin-2 (IL-2) Receptor
    Agonists pipeline depth and focus of Indication
    therapeutics  Developing strategic initiatives to
    support your drug development activities. Optimize
    your portfolio and keep you in touch with the
    rapidly changing pharmaceutical markets, and make
    the best decisions for your business.

6
Summary
  • Develop and design in licensing and out licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and Scope Provides
    strategically significant competitor information,
    analysis, and insights to formulate effective RD
    development strategies  Modify the therapeutic
    portfolio by identifying discontinued projects
    and understanding the factors that drove them
    from pipeline Gaining a Full Picture of the
    Competitive Landscape for Evidence based
    Decisions You can order full Report with TOC and
    for Sample page visit _at_ http//www.aarkstore.com/p
    harmaceuticals-healthcare/75780/interleukin-2-il-2
    -receptor-agonists-pipeline-insights-2014

7
Table of Content
  • Interleukin-2 (IL-2) Receptor Agonists
    Overview Interleukin-2 (IL-2) Receptor Agonists
    Disease Associated Interleukin-2 (IL-2) Receptor
    Agonists Pipeline Therapeutics Interleukin-2
    (IL-2) Receptor Agonists Therapeutics under
    Development by Companies  Interleukin-2 (IL-2)
    Receptor Agonists Late Stage Products (Filed and
    Phase III) Comparative Analysis  Interleukin-2
    (IL-2) Receptor Agonists Mid Clinical Stage
    Products (Phase II) Comparative
    Analysis  Interleukin-2 (IL-2) Receptor Agonists
    Early Clinical Stage Products (Phase I and IND
    Filed) Comparative Analysis  Interleukin-2 (IL-2)
    Receptor Agonists Discovery and Pre-Clinical
    Stage Products  Comparative Analysis  Drug
    Candidate Profiles

8
Table of Content
  • Interleukin-2 (IL-2) Receptor Agonists
    Therapeutics Assessment  Assessment by
    Monotherapy Products  Assessment by Combination
    Products  Assessment by Route of
    Administration  Assessment by Molecule
    Type  Interleukin-2 (IL-2) Receptor Agonists
    Discontinued Products  Interleukin-2 (IL-2)
    Receptor Agonists Dormant Products Companies
    Involved in Therapeutics Development for
    Interleukin-2 (IL-2) Receptor Agonists  Appendix 
    Methodology  Contact Us  Disclaimer

9
List of Tables
  • Number of Products under Development for
    Interleukin-2 (IL-2) Receptor Agonists by Therapy
    Area, 2014 Number of Products under Development
    for Interleukin-2 (IL-2) Receptor Agonists,
    2014 Number of Products under Development by
    Companies  Comparative Analysis by Late Clinical
    Stage Products (Filed and Phase III),
    2014 Comparative Analysis Mid Clinical Stage
    Products (Phase II), 2014 Comparative Analysis
    Early Clinical Stage Products (Phase I and IND
    Filed), 2014 Comparative Analysis Discovery and
    Pre-Clinical Stage Products, 2014 Drug Candidates
    Profiles

10
List of Tables
  • Interleukin-2 (IL-2) Receptor Agonists Assessment
    by Monotherapy Products  Interleukin-2 (IL-2)
    Receptor Agonists Assessment by Combination
    Products  Interleukin-2 (IL-2) Receptor Agonists
    Assessment by Route of Administration  Interleukin
    -2 (IL-2) Receptor Agonists Assessment by Stage
    and Route of Administration  Interleukin-2 (IL-2)
    Receptor Agonists Assessment by Molecule
    Type  Interleukin-2 (IL-2) Receptor Agonists
    Assessment by Stage and Molecule
    Type  Interleukin-2 (IL-2) Receptor Agonists
    Therapeutics Discontinued Products  Interleukin-2
    (IL-2) Receptor Agonists Therapeutics Dormant
    Products Products under Development by Companies,
    2014

11
List of Figures
  • Number of Products under Development for
    Interleukin-2 (IL-2) Receptor Agonists by Therapy
    Area, 2014 Number of Products under Development
    for Interleukin-2 (IL-2) Receptor Agonists,
    2014 Late Clinical Stage Products (Filed and
    Phase III), 2014 Mid Clinical Stage Products
    (Phase II), 2014 Early Clinical Stage Products
    (Phase I and IND Filed), 2014 Discovery and
    Pre-Clinical Stage Products, 2014 Interleukin-2
    (IL-2) Receptor Agonists Assessment by
    Monotherapy Products  Interleukin-2 (IL-2)
    Receptor Agonists Assessment by Combination
    Products  Interleukin-2 (IL-2) Receptor Agonists
    Assessment by Route of Administration  Interleukin
    -2 (IL-2) Receptor Agonists Assessment by Stage
    and Route of Administration  Interleukin-2 (IL-2)
    Receptor Agonists Assessment by Molecule
    Type  Interleukin-2 (IL-2) Receptor Agonists
    Assessment by Stage and Molecule Type

12
Related Reports
  • 2015 Worldwide Medical Laboratories
    Industry-Industry Market Report
  • 2015 Worldwide Pharmaceutical Preparation Mfg.
    Industry-Industry Market Report
  • OncoPlex Diagnostics - Pharmaceuticals
    Healthcare - Deals and Alliances Profile
  • MetaStat, Inc. - Pharmaceuticals Healthcare -
    Deals and Alliances Profile
  • Advanced Cell Diagnostics, Inc. - Pharmaceuticals
    Healthcare - Deals and Alliances Profile
  • Ascension Health - Pharmaceuticals Healthcare -
    Deals and Alliances Profile
  • Accretive Health, Inc. (ACHI) - Strategic SWOT
    Analysis Review
  • Jazz Pharmaceuticals plc (JAZZ) - Financial and
    Strategic SWOT Analysis Review
  • Pharmstandard (PHST) - Financial and Strategic
    SWOT Analysis Review
  • GLG Life Tech Corporation (GLG) - Financial and
    Strategic SWOT Analysis Review

13
  • Interleukin-2 (IL-2) Receptor Agonists -Pipeline
    Insights, 2014
  • Published Dec. 2014 60 Pages
  • DelveInsights,Interleukin-2 (IL-2) Receptor
    Agonists-Pipeline Insights, 2014, report provides
    comprehensive insights about pipeline drugs
    across this mechanism of action (MOA).
    Price

Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
14
Contact Us
Office Office No. - 809, 8th Floor, B-Wing,
Mahaavir Icon,  Plot No.- 89 90,
Sector-15, CBD-Belapur, Navi Mumbai
400614,  Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog
  • http//www.aarkstore.com/blog/
  • Conference
  • http//conference.aarkstore.com/
  • News
  • http//www.aarkstore.com/news
About PowerShow.com